At a glance
ClinicalIndex Comparison RecordN/ACompleted· 52 enrolled
Drug / intervention
CytoSorbdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery
In Brief
A clinical study evaluating CytoSorb for Elective Cardiac Surgery. Completed, enrolled 52 participants across 8 sites.
Detailed Summary
Prospective, multi-center, randomized, feasibility clinical study. Subjects will be randomized in a 1:1 ratio to either standard of care (SOC) alone or standard of care and treatment with the CytoSorb® device.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsElective Cardiac Surgery
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedOct 2015
Enrollment StartNov 2015
Primary CompletionOct 2016
Study CompletionDec 2016
TodayJul 2026
First PostedOct 2, 2015
Enrollment StartNov 1, 2015
Primary CompletionOct 1, 2016
Study CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 10.8 years ago
Interventions
CytoSorbdevice
Cytosorb device use during cardiopulmonary bypass